Health

Together for Health - Parenting the Future: Symposium on Fertility Support and Childcare Development in Rural Areas Held in Xi'an, China

* Hupan Modou Foundation and Shaanxi Provincial Government foster innovation through multi-party cooperation to enhance rural childcare services * Parenting the future: After 5 years of development and wide-reaching impact, Hupan Modou launches project in Zhenba,Shaanxi XI'AN, China, June 20, ...

2023-06-20 11:53 1053

Curocell announced encouraging updates on the next-generation anti-CD19 CAR-T, Anbalcabtagene-autoleucel at International Conference on Malignant Lymphoma (ICML) 2023

* 84% ORR (32 of 38 patients) and 71% CR (27 of 38 patients) documented after 2 million cells/kg dose anbal-cel treatment to patients in relapsed/refractory large B-cell lymphoma * Durable complete response was measured-68% at 1 month, 61% at 3 months, and 60% at 6 months respectively. DAEJEO...

2023-06-20 08:01 1064

Bergen Prepares to Host International Conference on Hansen's Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus

TOKYO, June 19, 2023 /PRNewswire/ -- The Sasakawa Leprosy (Hansen's Disease) Initiative and theUniversity of Bergen are organizing a two-day conference in Bergen, Norway, on June 21-22, 2023, to commemorate the 150th anniversary of the discovery ofM. leprae, the causative agent of leprosy, in 187...

2023-06-19 19:00 1696

The Summit Forum on the Application and Construction of AGP in China Takes Place in Shenzhen

SHENZHEN, China, June 19, 2023 /PRNewswire/ -- On June 9, the Summit Forum on the Application and Construction of AGP inChina, led by the National Innovation Center for Advanced Medical Devices, sponsored by China AGP and Digital Therapeutics R&D Center (hereafter referred to as the "R&D Center")...

2023-06-19 16:00 1766

The exchanges between China and Austria on TCM have yielded fruitful results

BEIJING, June 19, 2023 /PRNewswire/ -- A news report by haiwainet.cn: China and Austria have a long history of exchanges in The Traditional Chinese Medicine (TCM). InJuly 2005, the two countries signed a memorandum of understanding on cooperation in TCM. Under the framework of this cooperation a...

2023-06-19 13:28 1394

MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE

SUZHOU, China, June. 16, 2023  /PRNewswire/ -- The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of the biggest academic gatherings that celebrate the latest accomplishments in technological inn...

2023-06-17 07:04 3908

China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HANGZHOU, China, June 16, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that on J...

2023-06-17 04:29 6483

The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

NANJING, China, June 16, 2023 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs" or "Company") today announces that the phase I/II clinical trial application for LBL-033, an anti-MUC16/CD3 bispecific antibody, for the treatment of ovarian cancer and other m...

2023-06-16 22:01 2294

SeekIn paves the way for cancer early detection in low- and middle-income countries

OncoSeek® is a revolutionary multi-cancer early detection (MCED) test developed by SeekIn and empowered by AI technology to significantly reduce the false positive rate compared to the conventional clinical method thus increasing the specificity from 56.9% to 92.9%. In all cancer types, the overa...

2023-06-16 21:00 2191

Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca

SHANGHAI, June 16, 2023 /PRNewswire/ -- Cholesgen (Shanghai) Co.Ltd. ('Cholesgen') today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug...

2023-06-16 18:00 2344

Singleron launches two new instruments to further standardize single cell analysis workflow

COLOGNE, Germany, June 16, 2023 /PRNewswire/ -- "We care for your samples, you care for science" – Singleron holds true to their slogan as reliable partner to scientists and clinicians. Developing single cell multi-omics products that can be used in research and clinical settings, the launch of t...

2023-06-16 16:18 1942

DeerRun Launches Women's Exclusive Smart Under-Desk Treadmill

HOUSTON, June 15, 2023 /PRNewswire/ -- DeerRun is a treadmill brand designed specifically for women, with careful research and optimization for height, weight, and exercise habits of women inEurope and America. Recently, DeerRun launched a new smart under-desk treadmill - BA02, which can be remot...

2023-06-16 08:30 1839

BrightMD Fair China 2023 Concludes Successfully, Fostering Collaborative Synergies in Shenzhen

SHENZHEN, China, June 15, 2023 /PRNewswire/ -- BrightMD Fair China 2023, with the theme "Bringing Together Cutting-edge Innovation to Create A Smart Manufacturing Hub", was held onJune 8-10 at the Shenzhen Convention and Exhibition Center in Futian District,Shenzhen. The exhibition, recognized a...

2023-06-15 21:02 1824

China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results

HANGZHOU, China, June 15, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced its finan...

2023-06-15 21:00 4624

Mabwell Publishes the Preclinical Study Results on Its Nectin-4 Targeting ADC in A Well-known AACR Journal

SHANGHAI, June 15, 2023 /PRNewswire/ -- Recently, the preclinical study results of 9MW2821, the first domestically developed Nectin-4-targeting ADC by Mabwell, were published in the renowned journal "Molecular Cancer Therapeutics" under the American Association for Cancer Research (AACR). The pap...

2023-06-15 21:00 2097

Mabwell Announces the U.S. FDA approval of 9MW3811 for IND

SHANGHAI, June 15, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the entire value chain of the pharmaceutical industry, announced the clinical trial application of its self-developed 9MW3811 injection for idiopathic pulmonary fibrosis has been approved by ...

2023-06-15 21:00 2073

Vatech's EzRay Air Series Continues to achieve Record-Breaking Sales Performance Worldwide

SEOUL, South Korea, June 15, 2023 /PRNewswire/ -- Vatech, a global leader in the dental imaging market, reported that the digital Intraoral x-ray generator 'EzRay Air' series has already been adopted by 50,000 dentists around the world. This groundbreaking product, featuring CNT X-ray technology ...

2023-06-15 21:00 1700

Addentax Group Corp. in Advanced Talks to Acquire Partial Stake in RMB 6 Billion-Valued Recombinant Protein Drugs and Antibody Drugs Bio-pharmaceutical Company, Shanghai Bao Pharmaceutical Company Limited

SHENZHEN, China, June 15, 2023 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG), an integrated service provider focusing on garment manufacturing, logistics services, property management and subleasing, and epidemic prevention supplies, today announced that it is ...

2023-06-15 20:00 4043

FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer

SAN FRANCISCO, June 15, 2023 /PRNewswire/ -- Biostar Pharma, Inc. (hereinafter referred to as "Biostar"), the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative...

2023-06-15 19:31 1800

Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer

June 21, 2023, at The Yale Club, New York City  Featured speakers and Key Opinion Leaders include: Dr Christian Behrenbruch, DrColin Hayward, Kevin Richardson, Dr Brian Shuch and Dr Scott Tagawa Topics include Telix's urologic pipeline, development of novel therapeutics, imaging agents and techn...

2023-06-15 19:00 1798
1 ... 78798081828384 ... 273